Bristol Laboratories has recently acquired manufacturing facility at Luton to produce solid dosage forms like tablets, capsules and powders for sachets. Highlights of the manufacturing facility: • MHRA approved facility; comply with EC Directive on GMP • Plant approved under SGS Supplier Approval Scheme • Site Approved by UK Home Office for manufacture of controlled drugs • Quality Control laboratory approved by SGS • Dedicated Sachet Line • Ideally located at close proximity to London. Easy accessibility for motorways M1 and M25 and for Luton and Heathrow airports. • Compact single unit facility (44,000 sq. ft) • MHRA approved warehouse and storage premises • Houses manufacturing, packaging, warehousing, laboratory and office facility Capacities On a single shift basis, the annual manufacturing capacities are as follows: Processes Capacities Tablets 2.1 billion units Capsule 300 million units Sachet 20 million units Quality Policy We are in the business of manufacturing & marketing both generic & branded pharmaceutical products for both domestic and international market We strive to produce quality products in accordance with the national & international regulatory requirement through: Continuous quality improvement system Impart proper training to concern employees in quality management systems and cGMP Maintain required health, safety & environmental standards Maintain an effective positive customer interface Services Bristol Laboratories Ltd. is also able to provide contract manufacturing & packaging facilities for …. Tablets Capsules Sachets Special features of our contract manufacturing facilities: Formulation development Protocol development. Pilot scale batches through to commercial production Stability studies in lines with ICH guidelines Development and Validation of analytical methods QP released goods for EU market. For more information regarding contract manufacturing and packing services please write to info@bristol-labs.co.uk
Home Company Products Manufacturing Contact ©2004